Pyrrocidine A is a known antimicrobial compound produced by endophytic fungi and has a unique 13-membered macrocyclic
alkaloid structure with an α,β-unsaturated carbonyl group. We have previously reported that
pyrrocidine A shows potent cytotoxicity against human
acute promyelocytic leukemia HL60 cells, and the activity is 70-fold higher than that of
pyrrocidine B which is the analog lacking the α,β-unsaturated carbonyl group.
Pyrrocidine A induced nuclear condensation, DNA fragmentation and
caspase activation in HL60 cells. Since the DNA fragmentation was suppressed by pretreatment with the pan-
caspase inhibitor,
benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (
z-VAD-fmk),
caspase-mediated apoptosis contributes to
pyrrocidine A-induced cytotoxicity. JFCR39 human
cancer cells panel indicated that the mechanism of action of
pyrrocidine A is different from other clinical anticancer drugs, and this compound broadly inhibited the growth of various
cancer cell lines. The apoptosis induction by
pyrrocidine A was suppressed by both
N-acetyl-l-cysteine (NAC) and
glutathione, both of which are
thiol-containing
antioxidants. Furthermore,
pyrrocidine A directly bound to
N-acetyl-l-cysteine methyl
ester (NACM) through the Michael-type addition at the α,β-unsaturated carbonyl group and was detected by HPLC and liquid chromatography-ESI-tandem MS (LC-ESI-MS/MS) analyses. This indicates that this moiety is crucial for the potent apoptosis-inducing activity of
pyrrocidine A.